{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:38:42Z","timestamp":1784547522102,"version":"3.55.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cancer-associated secondary lymphedema (CASL) commonly occurs after tumor-related lymph node dissection and radiotherapy. Nevertheless, the mechanisms of CASL remain unclear, and there are no specific molecular markers for its diagnosis and treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, RNA sequencing was performed on adipose tissues from 10 normal controls and 40 patients with CASL. Differentially expressed genes were screened using two machine learning algorithms to identify potential molecular markers for CASL. Subsequently, seven machine learning algorithms were employed to develop predictive models based on the identified markers. The contribution of each feature to the predictive outcomes was interpreted using Shapley additive explanation (SHAP). Immune cell infiltration was profiled through CIBERSORT and MCP-counter algorithms, and single-cell RNA sequencing (scRNA-seq) data were integrated to explore interactions between characteristic genes and immune cell subpopulations. Furthermore, associations between characteristic genes and clinical parameters were also assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>IL2RG, HOXD10, and TSPAN1 were identified as potential biomarkers of CASL. Diagnostic models built on these three genes showed excellent performance. Functional enrichment analysis suggested that the dysregulation of cytokine-cytokine receptor interactions and immune pathways underlies the pathological progression of CASL. In addition, immune infiltration analysis indicated that T cell and macrophage infiltration were intricately involved in CASL progression. Intriguingly, single-cell transcriptomic analysis further revealed elevated expression of IL2RG, HOXD10, and TSPAN1 in T cell subsets. Finally, RT-qPCR validated that these genes were expressed at higher levels in CASL tissues than in normal tissues. Moreover, IL2RG expression was strongly associated with clinical parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study identified IL2RG, HOXD10, and TSPAN1 as novel potential molecular markers for CASL, providing valuable biological evidence for the diagnosis and intervention of CASL.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1760040","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T05:22:45Z","timestamp":1770960165000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Uncovering potential molecular biomarkers for cancer-associated secondary lymphedema through integrated analyses of RNA-sequencing, machine learning, and clinical data"],"prefix":"10.3389","volume":"16","author":[{"given":"Hao","family":"Dong","sequence":"first","affiliation":[{"name":"Department of Lymphatic Surgery, Capital Medical University Affiliated Beijing Shijitan Hospital","place":["Beijing, China"]},{"name":"Clinical Center for Lymphatic Disorders, Capital Medical University (CMU)","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianliang","family":"Miao","sequence":"additional","affiliation":[{"name":"First Affiliated Hospital of Dalian Medical University, Dalian Medical University","place":["Dalian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Lymphatic Surgery, Capital Medical University Affiliated Beijing Shijitan Hospital","place":["Beijing, China"]},{"name":"Clinical Center for Lymphatic Disorders, Capital Medical University (CMU)","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuguang","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Lymphatic Surgery, Capital Medical University Affiliated Beijing Shijitan Hospital","place":["Beijing, China"]},{"name":"Clinical Center for Lymphatic Disorders, Capital Medical University (CMU)","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peilin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Lymphatic Surgery, Capital Medical University Affiliated Beijing Shijitan Hospital","place":["Beijing, China"]},{"name":"Clinical Center for Lymphatic Disorders, Capital Medical University (CMU)","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Lymphatic Surgery, Capital Medical University Affiliated Beijing Shijitan Hospital","place":["Beijing, China"]},{"name":"Clinical Center for Lymphatic Disorders, Capital Medical University (CMU)","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Lymphatic Surgery, Capital Medical University Affiliated Beijing Shijitan Hospital","place":["Beijing, China"]},{"name":"Clinical Center for Lymphatic Disorders, Capital Medical University (CMU)","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.06.039","article-title":"The lymphatic vasculature in the 21st century: novel functional roles in homeostasis and disease","volume":"182","author":"Oliver","year":"2020","journal-title":"Cell"},{"key":"B2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41572-019-0072-5","article-title":"Cancer-associated secondary lymphoedema","volume":"5","author":"Rockson","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1080\/02648725.2023.2195082","article-title":"Phospholipase A2 (PLA2) injured lymphatic endothelial cells leading to progression of secondary lymphoedema","volume":"40","author":"Zhao","year":"2024","journal-title":"Biotechnol Genet Eng Rev"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2023-004811","article-title":"Prophylactic complex physiotherapy in gynecologic cancer survivors: patient-reported outcomes based on a lymphedema questionnaire","volume":"33","author":"Daggez","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e221671","DOI":"10.1001\/jamanetworkopen.2022.1671","article-title":"Association of lower extremity lymphedema with physical functioning and activities of daily living among older survivors of colorectal, endometrial, and ovarian cancer","volume":"5","author":"Zhang","year":"2022","journal-title":"JAMA Netw Open"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70076-7","article-title":"Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis","volume":"14","author":"DiSipio","year":"2013","journal-title":"Lancet Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1089\/lrb.2021.0076","article-title":"Clinical significance of serum collagen type IV and procollagen type III N-peptide levels in diagnosis and differential diagnosis of lymphedema","volume":"21","author":"Meng","year":"2023","journal-title":"Lymphat Res Biol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.732415","article-title":"Crosstalk between microRNAs and the pathological features of secondary lymphedema","volume":"9","author":"Yusof","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00076","article-title":"Modulation of immunity by lymphatic dysfunction in lymphedema","volume":"10","author":"Yuan","year":"2019","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/02683555231209056","article-title":"Application of complete decongestive therapy after lymphaticovenular anastomosis of the lower limb combined with liposuction-A retrospective study research","volume":"39","author":"Zhou","year":"2024","journal-title":"Phlebology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-019-05101-8","article-title":"What are the economic burden and costs associated with the treatment of breast cancer-related lymphoedema? A systematic review","volume":"28","author":"De Vrieze","year":"2020","journal-title":"Support Care Cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13045-020-00974-3","article-title":"The altered transcriptome of pediatric myelodysplastic syndrome revealed by RNA sequencing","volume":"13","author":"Zubovic","year":"2020","journal-title":"J Hematol Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1089\/lrb.2020.0030","article-title":"Possible role of the RORC gene in primary and secondary lymphedema: review of the literature and genetic study of two rare causative variants","volume":"19","author":"Michelini","year":"2021","journal-title":"Lymphat Res Biol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/dom.15933","article-title":"Integrated approach of machine learning, Mendelian randomization and experimental validation for biomarker discovery in diabetic nephropathy","volume":"26","author":"Zhu","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S488676","article-title":"Integrating machine learning and the SHapley additive exPlanations (SHAP) framework to predict lymph node metastasis in gastric cancer patients based on inflammation indices and peripheral lymphocyte subpopulations","volume":"17","author":"Zhu","year":"2024","journal-title":"J Inflammation Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2458\/lymph.6372","article-title":"The diagnosis and treatment of peripheral lymphedema: 2023 consensus document of the international society of lymphology","volume":"56","year":"2023","journal-title":"Lymphology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41598-021-04390-6","article-title":"Epithelial-mesenchymal transition related genes in unruptured aneurysms identified through weighted gene coexpression network analysis","volume":"12","author":"Jiang","year":"2022","journal-title":"Sci Rep"},{"key":"B18","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41421-022-00402-5","article-title":"Single-cell RNA sequencing of subcutaneous adipose tissues identifies therapeutic targets for cancer-associated lymphedema","volume":"8","author":"Liu","year":"2022","journal-title":"Cell Discov"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/micr.20772","article-title":"Types of lymphoscintigraphy and indications for lymphaticovenous anastomosis","volume":"30","author":"Maegawa","year":"2010","journal-title":"Microsurgery"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.2458\/lymph.4649","article-title":"The diagnosis and treatment of peripheral lymphedema: 2020 Consensus Document of the International Society of Lymphology","volume":"53","year":"2020","journal-title":"Lymphology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-020-06790-0","article-title":"MRI staging of upper extremity secondary lymphedema: correlation with clinical measurements","volume":"30","author":"Kim","year":"2020","journal-title":"Eur Radiol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2354.1995.tb00047.x","article-title":"Volume measurement in lymphoedema treatment: examination of formulae","volume":"4","author":"Sitzia","year":"1995","journal-title":"Eur J Cancer Care (Engl)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.858166","article-title":"Novel IL2RG gene mutation in one of dizygotic twins causing profound changes of receptor structure","volume":"10","author":"Rutkowska-Zapa\u0142a","year":"2022","journal-title":"Front Pediatr"},{"key":"B24","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41392-023-01544-y","article-title":"Generation of inactivated IL2RG and RAG1 monkeys with severe combined immunodeficiency using base editing","volume":"8","author":"Zheng","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1387975","article-title":"Regulation of Treg cells by cytokine signaling and co-stimulatory molecules","volume":"15","author":"Zong","year":"2024","journal-title":"Front Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e89081","DOI":"10.1172\/jci.insight.89081","article-title":"Regulatory T cell transfer ameliorates lymphedema and promotes lymphatic vessel function","volume":"1","author":"Gousopoulos","year":"2016","journal-title":"JCI Insight"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112329","article-title":"Toxicarioside H-mediated modulation of the immune microenvironment attenuates ovalbumin-induced allergic airway inflammation by inhibiting NETosis","volume":"136","author":"Zhang","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1159\/000376579","article-title":"The interleukin-13 receptor-\u03b11 chain is essential for induction of the alternative macrophage activation pathway by IL-13 but not IL-4","volume":"7","author":"Sheikh","year":"2015","journal-title":"J Innate Immun"},{"key":"B29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1089\/lrb.2013.0024","article-title":"Cytokine candidate genes predict the development of secondary lymphedema following breast cancer surgery","volume":"12","author":"Leung","year":"2014","journal-title":"Lymphat Res Biol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2024.107178","article-title":"IL20Rb aggravates pulmonary fibrosis through enhancing bone marrow derived profibrotic macrophage activation","volume":"203","author":"Zhu","year":"2024","journal-title":"Pharmacol Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/804675","article-title":"Lymphedema and therapeutic lymphangiogenesis","volume":"2013","author":"Saito","year":"2013","journal-title":"BioMed Res Int"},{"key":"B32","first-page":"4","article-title":"HOX genes and the limb development in the clinical praxis and in the experiment","volume":"149","author":"Snajdr","year":"2010","journal-title":"Cas Lek Cesk"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-018-0316-0","article-title":"Epigenetic inactivation of HOXD10 is associated with human colon cancer via inhibiting the RHOC\/AKT\/MAPK signaling pathway","volume":"17","author":"Yuan","year":"2019","journal-title":"Cell Commun Signal"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.186767","article-title":"DeepCAGE transcriptomics identify HOXD10 as a transcription factor regulating lymphatic endothelial responses to VEGF-C","volume":"129","author":"Klein","year":"2016","journal-title":"J Cell Sci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2021.188674","article-title":"TSPAN1, a novel tetraspanin member highly involved in carcinogenesis and chemoresistance","volume":"1877","author":"Garcia-Mayea","year":"2022","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.702510","article-title":"Tetraspanins: novel molecular regulators of gastric cancer","volume":"11","author":"Deng","year":"2021","journal-title":"Front Oncol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.723341","article-title":"Role of tetraspanins in hepatocellular carcinoma","volume":"11","author":"Cai","year":"2021","journal-title":"Front Oncol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.14258","article-title":"Tetraspanin 1 as a mediator of fibrosis inhibits EMT process and Smad2\/3 and beta-catenin pathway in human pulmonary fibrosis","volume":"23","author":"Liu","year":"2019","journal-title":"J Cell Mol Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2020.05.018","article-title":"Delivery of TSPAN1 siRNA by novel th17 targeted cationic liposomes for gastric cancer intervention","volume":"109","author":"Lu","year":"2020","journal-title":"J Pharm Sci"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1089\/lrb.2023.0002","article-title":"The function of T cell immunity in lymphedema: A comprehensive review","volume":"21","author":"Fu","year":"2023","journal-title":"Lymphat Res Biol"}],"updated-by":[{"DOI":"10.3389\/fonc.2026.1894847","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000}}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1760040\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T12:21:28Z","timestamp":1783599688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1760040\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":40,"alternative-id":["10.3389\/fonc.2026.1760040"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1760040","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"article-number":"1760040"}}